Apr 14, 2019
Ongoing HTA regarding SCID screening in newborns in Finland
In Finland, the Health Care Services Selection Council (Terveydenhuollon palveluvalikoimaneuvosto, PALKO) is responsible for making recommendations regarding the research, treatment and rehabilitation methods. The assessment procedure includes the overview of the research data, evidence, ethical and organizational aspects of healthcare. The Council provides the recommendation whether the method is a part of publicly funded services or not.

Currently, PALKO is working on the only one assessment related to in-vitro diagnostics:
  • Screening for a Serious Combined Immune Deficiency (SCID) from Newborn Heel
Initially, the recommendations are published at the web-site of the Council as drafts and could receive the feedback which would be considered during the preparation of completed report. The final versions could be found here.

See the full information in Finnish here.
This website uses cookies to ensure you get the best experience on our website. By carrying on browsing, you are giving your consent for us to set cookies.

Learn more
Ok, I agree
Subscribe to newsletter
Subscribe to our newsletter to get regular updates from us on the changes of reimbursement systems (>100 reimbursement stakeholders in 12 EU countries)